BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4528542)

  • 21. HL-A expression on the G1, S, and G2 cell-cycle stages of human lymphoid cells.
    Everson LK; Plocinik BA; Rogentine GN
    J Natl Cancer Inst; 1974 Oct; 53(4):913-20. PubMed ID: 4139277
    [No Abstract]   [Full Text] [Related]  

  • 22. Dynamic aspects of the interaction between antibodies and complement at the cell surface.
    Sundqvist KG; Svehag SE; Thorstensson RT
    Scand J Immunol; 1974; 3(3):237-50. PubMed ID: 4211939
    [No Abstract]   [Full Text] [Related]  

  • 23. Cultured human lymphoid cells: tools for the biological and molecular characterization of antigens and their recognition systems.
    Reisfeld RA; Pellegrino MA; Dierich MP; Ferrone S
    In Vitro; 1975; 11(4):173-85. PubMed ID: 51826
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay.
    Tanigaki N; Miyakawa Y; Yagi Y; Kreiter VP; Pressman D
    J Immunol Methods; 1973 Oct; 3(2):109-25. PubMed ID: 4127823
    [No Abstract]   [Full Text] [Related]  

  • 25. Rate of desensitization to HL-A antibodies in phytohaemagglutinin (PHA) stimulated lymphocytes.
    Rugarli C; Scorza R; Sabbadini MG
    Boll Ist Sieroter Milan; 1974; 53(4):573-7. PubMed ID: 4476215
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta2-microglobulin on the cell surface. Relationship to HL-A antigens and the mixed leucocyte culture reaction.
    Lindblom JB; Ostberg L; Peterson PA
    Tissue Antigens; 1974; 4(2):186-96. PubMed ID: 4134649
    [No Abstract]   [Full Text] [Related]  

  • 27. Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement binding.
    Pellegrino MA; Ferrone S; Cooper NR; Dierich MP; Reisfeld RA
    J Exp Med; 1974 Aug; 140(2):578-90. PubMed ID: 4527075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The serologic detection of HL-A antigens in human milk.
    Dawson JR; Shasby SS; Amos DB
    Tissue Antigens; 1974; 4(1):76-82. PubMed ID: 4858061
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell growth cycle and expression of histocompatibility antigens on cultured human lymphoid cells.
    Ferrone S; Polli EE
    Haematologica; 1974 Mar; 59(1):25-37. PubMed ID: 4212983
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute leukemia-associated antigens.
    Mann DL; Halterman R; Leventhal B
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1446-51. PubMed ID: 4370857
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro conversion of normal mouse lymphocytes by plasmacytoma RNA to express idiotypic specificities on their surface characteristic of the plasmacytoma immunoglobulin.
    Giacomoni D; Yakulis V; Wang SR; Cooke A; Dray S; Heller P
    Cell Immunol; 1974 Mar; 11(1-3):389-400. PubMed ID: 4616765
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiserum to a soluble lymphoid membrane preparation stimulates human leukocyte DNA synthesis.
    Einstein AB; Mann DL; Ficker S; Terry WD
    J Immunol; 1971 Oct; 107(4):1205-8. PubMed ID: 5129731
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody-dependent lymphocyte-mediated cytotoxicity in an allogeneic human system. II. Evidence for HL-A specificity.
    Dickmeiss E; Nielsen LS
    Scand J Immunol; 1974; 3(2):199-207. PubMed ID: 4822686
    [No Abstract]   [Full Text] [Related]  

  • 34. Membrane antigens characteristic of human lymphoid cells in established cultures.
    Thieme TR; Colombe BW
    Tissue Antigens; 1974; 4(3):210-7. PubMed ID: 4137060
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera.
    Brochier J; Roitt IM; Festenstein H
    Eur J Immunol; 1974 Nov; 4(11):709-15. PubMed ID: 4279178
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenotypic suppression of H-2 antigens and topography of the cell surface.
    Lengerová A; Pokorná Z; Viklický V; Zelený V
    Tissue Antigens; 1972; 2(4):332-40. PubMed ID: 4586482
    [No Abstract]   [Full Text] [Related]  

  • 37. The immunoglobulin-like structure of human histocompatibility antigens.
    Strominger JL; Cresswell P; Grey H; Humphreys RE; Mann D; McCuneJ ; Parham P; Robb R; Sanderson AR; Springer TA; Terhorst C; Turner MJ
    Transplant Rev; 1974; 21(0):126-43. PubMed ID: 4139785
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative studies on the rates of re-expression of human histocompatibility antigens after papain treatment.
    Bright S
    Tissue Antigens; 1974; 4(4):306-12. PubMed ID: 4412531
    [No Abstract]   [Full Text] [Related]  

  • 39. Defective activation of b5 bearing lymphocytes in rabbits recovering from b5 allotype suppression.
    Harrison MR; Elfenbein GJ; Mage RG
    Cell Immunol; 1974 Mar; 11(1-3):231-8. PubMed ID: 4455393
    [No Abstract]   [Full Text] [Related]  

  • 40. The immune reactivity of heterologous antisera against a solubilized human lymphoid membrane component.
    Einstein AB; Mann DL; Gordon HG; Fahey JL
    Tissue Antigens; 1971; 1(5):209-18. PubMed ID: 5172713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.